Projects per year
Personal profile
Areas of expertise
External responsibilities
Diplomas
Areas of expertise
External responsibilities
Diplomas
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Pharmacy, Thesis Drug design and developpment, Université de Liège
Award Date: 30 Jun 2000
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
MP-EMA: Belgian representation on the European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) 2024-2027
Dogne, J.-M. (PI)
1/07/24 → 30/07/27
Project: Research
-
BE-MICROPLAST-FOOD: Assessment of Belgian food consumption of microplastics
De Groote, A. (PI), Dogne, J.-M. (PI) & Beaudart, C. (PI)
1/02/24 → 31/01/25
Project: PHD
-
Management of (activated) factor eleven (FXI(a)) inhibitors
Vassart, J. (Researcher), Douxfils, J. (PI) & Dogne, J.-M. (Co-supervisor)
17/10/22 → …
Project: PHD
-
Clinical Pharmacology Research Group
Douxfils, J. (Supervisor), Dogne, J.-M. (Supervisor), Musuamba Tshinanu, F. (Supervisor), Masereel, B. (Supervisor), Wieërs, G. (Supervisor), Haguet, H. (Researcher), RONVAUX, L. (Researcher), Donis, N. (Researcher), Morimont, L. (Researcher), Evrard, J. (Researcher), Siriez, R. (Researcher), Gillot, C. (Researcher), FAVRESSE, J. (Researcher), BOUVY, C. (Researcher), Djokoto, H. (Researcher), Didembourg, M. (Researcher), David, C. (Support role), Melchionda, S. (Support role), Maloteau, V. (Technician), Boucher, A.-Y. (Technician), Devel, P. (Technician), Modaffari, E. (Technician), Vandeputte, M. (Technician), De Messemaeker, A. (Secretaire), Decarpentrie, J. (Researcher), Vassart, J. (Researcher) & De Groote, A. (Researcher)
1/04/22 → …
Project: Research Axis
-
The COVILAB project : Clinical laboratory investigations related to COVID-19
Douxfils, J. (Supervisor), Dogne, J.-M. (Co-supervisor), FAVRESSE, J. (CoI), Tre-Hardy, M. (CoI), Mullier, F. (CoI), Haguet, H. (Researcher), Hardy, M. (Researcher), Melchionda, S. (Researcher), BOUVY, C. (Researcher), Morimont, L. (Researcher), Gillot, C. (Researcher), Djokoto, H. (Researcher), Alpan, L. (Technician), Devel, P. (Technician), Modaffari, E. (Technician) & Maloteau, V. (Technician)
13/03/20 → …
Project: Research
-
An Evaluation of a SARS-CoV-2 Pseudovirus Neutralization Test and A Comparison to a SARS-CoV-2 Surrogate Virus Neutralization Test in a COVID-19 Long-Term Follow-Up Cohort
Gillot, C., Favresse, J., David, C., Maloteau, V., Dogne, J. M. & Douxfils, J., 21 Mar 2024, In: Microbiology Research. 15, 1, p. 422-430 9 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Downloads (Pure) -
Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis
Douxfils, J., Raskin, L., Didembourg, M., Donis, N., Dogné, J.-M., Morimont, L. & Beaudart, C., 2024, In: Frontiers in endocrinology. 15, p. 1428597Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273
Gillot, C., Tré-Hadry, M., Cupaiolo, R., Blairon, L., Wilmet, A., Beukinga, I., Dogné, J.-M., Douxfils, J. & Favresse, J., Jul 2024, In: Virology. 595, p. 110082 110082.Research output: Contribution to journal › Article › peer-review
Open Access -
Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?
Vassart, J., Didembourg, M., Morimont, L., Brisbois, C., Jamart, L., Lebreton, A., Mullier, F., Donis, N., Favresse, J., Dogne, J.-M. & Douxfils, J., 7 Mar 2024, In: Thrombosis Research. 236, April 2024, p. 236-239 4 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile44 Downloads (Pure) -
Corrigendum to "Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?” [Thromb. Res. 236 (2024) 236–239 TR_8963, (S0049384824000732), (10.1016/j.thromres.2024.03.001)]
Vassart, J., Didembourg, M., Morimont, L., Brisbois, C., Jamart, L., Lebreton, A., Mullier, F., Donis, N., Favresse, J., Dogné, J.-M. & Douxfils, J., Aug 2024, In: Thrombosis Research. 240, p. 109066 109066.Research output: Contribution to journal › Comment/debate › peer-review
Datasets
-
CCDC 1017214: Experimental Crystal Structure Determination
Damas, J. (Contributor), de Leval, X. (Contributor), DOGNE, J.-M. (Contributor), Julémont, F. (Contributor), Michaux, C. (Contributor), MONTERO, J.-L. (Contributor), Pirotte, B. (Contributor), Renard, J.-F. (Contributor) & WINUM, J.-Y. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2014
DOI: 10.5517/cc134hc3, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/cc134hc3&sid=DataCite
Dataset
-
CCDC 1017215: Experimental Crystal Structure Determination
Damas, J. (Contributor), de Leval, X. (Contributor), DOGNE, J.-M. (Contributor), Julémont, F. (Contributor), Michaux, C. (Contributor), MONTERO, J.-L. (Contributor), Pirotte, B. (Contributor), Renard, J.-F. (Contributor) & WINUM, J.-Y. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2014
DOI: 10.5517/cc134hd4, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/cc134hd4&sid=DataCite
Dataset
-
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), Chatelain, C. (Contributor), Mullier, F. (Contributor), Haguet, H. (Contributor), DOGNE, J.-M. (Contributor) & Douxfils, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
Prizes
-
Prix Léo Pharma Cancer & Thrombosis
Haguet, H. (Recipient), Douxfils, J. (Recipient), Mullier, F. (Recipient) & Dogne, J.-M. (Recipient), 25 Feb 2017
Prize: Prize (including medals and awards)
Activities
- 6 Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Haguet, H. (Speaker), Douxfils, J. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker), Mullier, F. (Speaker) & Dogne, J.-M. (Speaker)
9 Feb 2018Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
25 Feb 2017Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
28 Apr 2016Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
29 Jan 2016Activity: Talk or presentation types › Oral presentation
Press/Media
-
Minutes of the PRAC meeting 8-11 July 2024
10/09/24
1 item of Media coverage
Press/Media: Expert Comment
-
University of Namur Researchers Detail New Studies and Findings in the Area of Vaccines [Vaccine-induced humoral response of BNT162b2 and mRNA-1273 against BA.1, BA.5, and XBB.1.5. (sub)variants 6 months after a homologous booster: is ...]
Dogne, J.-M., Douxfils, J., Tre-Hardy, M., FAVRESSE, J. & Gillot, C.
4/09/24
1 item of Media coverage
Press/Media: Expert Comment
-
-
Agenda of the PRAC meeting 10-13 June 2024
10/06/24
1 item of Media coverage
Press/Media: Expert Comment
-
Minutes of the PRAC meeting 4-7 March 2024
14/05/24
1 item of Media coverage
Press/Media: Expert Comment